De novo gastrointestinal tumours after renal transplantation: Role of CMV and EBV viruses

Clinical Transplantation

Volumn 20, Issue 4, 2006, Pages 457-460

  Adani, Gian Luigi ^a   Baccarani, Umberto ^a   Lorenzin, Dario ^a   Gropuzzo, Maria ^b   Tulissi, Patrizia ^b   Montanaro, Domenico ^b   Currö, Giuseppe ^a   Sainz, Mauricio ^a   Risaliti, Andrea ^a   Bresadola, Vittorio ^a   Bresadola, Fabrizio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cytomegalovirus; Epstein Barr virus; Gastrointestinal de novo tumours; Kidney transplantation

Indexed keywords

CYCLOSPORIN A; FLUOROURACIL; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; COLONOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM CANCER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROSCOPY; HUMAN; IMMUNE DEFICIENCY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CANCER; STOMACH CANCER; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS REACTIVATION;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTROINTESTINAL NEOPLASMS; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 33745625635     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00505.x     Document Type: Article

References (21)

1. Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 2005: 352: 1371.
2. Tremblay F, Fernandes M, Habbab F, De B, Edwardes MD, Loertscher R, Meterissian S. Malignancy after renal transplantation: Incidence and role of type of immunosuppression. Ann Surg Oncol 2002: 9: 785.
3. Pedotti P, Cardillo M, Rossini G et al. Incidence of cancer after kidney transplant: Results from the North Italy transplant program. Transplantation 2003: 76: 1448.
4. European Dialysis and Transplantation Association-European Renal Association, Brunner FP Landais P, Selwood NH. Malignancies after renal transplantation: The EDTA-ERA registry experience. Nephrol Dial Transplant 1995: 10 (Suppl. 1): 74.
5. Letsou G, Ballantyne GH, Zdon IM, Cambria RM, Modlin IM. Rectal carcinoma in a renal transplant patient. Long-term complication of immunosuppression? Dis Colon Rectum 1986: 29: 133.
6. Newstead CG. Assessment of risk of cancer after renal transplantation. Lancet 1998: 351: 610.
7. Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Transplant Proc 2003: 35: 1410.
8. Feczko PJ, Mezwa DG. Gastrointestinal carcinomas in renal transplant recipients. Gastrointest Radiol 1991: 16: 351.
9. Ebisui C, Okazaki M, Kanai T et al. Clinicopathological study of colorectal cancers after renal transplantation. Transplant Proc 2000: 32: 1984.
10. Hart H, Neill WA, Norval M. Lack of association of cytomegalovirus with adenocarcinoma of the colon. Gut 1982: 23: 21.
11. Grail A, Norval M. Evolution of cytomegalovirus antibodies from adenocarcinoma of the colon. Gut 1985: 26: 1053.
12. Scott MH, Sells RA. Primary adenocarcinoma in a transplanted cadaveric kidney. Transplantation 1988: 46: 157.
13. Luo B, Wang Y, Wang XF et al. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol 2005: 11: 629.
14. Huang ES, Roche JK. Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection. Lancet 1978: 1: 957.
15. Oh ST, Seo JS, Moon UY et al. A naturally derived gastric cancer cell line shows latency I Epstein/Barr virus infection closely resembling EBV-associated gastric cancer. Virology 2004: 320: 330.
16. Grinstein S, Preciado MV, Gattuso P et al. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002: 62: 4876.
17. Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc 2005: 37: 960.
18. Suzuki T, Takano Y, Yamashita K, Sato K, Kakita A, Okudaira M. A possible role for Epstein-Barr virus in tumourigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol 1993: 119: 627.
19. Morelon E, Mamzer-Bruneel MF, Peraldi MN, Kreis H. Sirolimus: A new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrol Dial Transplant 2001: 16: 18.
20. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004: 77: 1777.
21. Koehl G, Guba M, Seeliger H et al. Rapamycin treatment at immunosuppressive doses affects tumour blood vessel circulation. Transplant Proc 2003: 35: 2135.